| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/21/2004 | DE10315538A1 Teilchen mit einer Membran Particles having a membrane |
| 10/21/2004 | DE10314082A1 Biodegradierbares injizierbares Implantat Biodegradable injectable implant |
| 10/21/2004 | DE10313272A1 Using hexadecylphosphocholine for treatment of actinic keratosis, by topical application as aqueous solution |
| 10/21/2004 | DE102004016947A1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 10/21/2004 | DE102004010921A1 Feste Oraldosierungsform von Metformin und Glyburid sowie ein Verfahren zu Ihrer Herstellung Oral solid dosage form of metformin and glyburide and a process for their preparation |
| 10/21/2004 | CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 10/21/2004 | CA2528001A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 10/21/2004 | CA2526869A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic exipient |
| 10/21/2004 | CA2522231A1 Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| 10/21/2004 | CA2522206A1 Oral administration form for veterinary use |
| 10/21/2004 | CA2522115A1 A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid |
| 10/21/2004 | CA2521902A1 Pharmaceutical combination comprising eletriptan and sodium bicarbonate |
| 10/21/2004 | CA2521637A1 Acoustic telemetry apparatus for intrabody communications |
| 10/21/2004 | CA2521603A1 Stable carprofen composition |
| 10/21/2004 | CA2521423A1 Drug delivery systems comprising an encapsulated active ingredient |
| 10/21/2004 | CA2520864A1 Lipid particles having asymmetric lipid coating and method of preparing same |
| 10/21/2004 | CA2520775A1 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 10/21/2004 | CA2520766A1 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 10/21/2004 | CA2520610A1 Osmotic pump with means for dissipating internal pressure |
| 10/21/2004 | CA2519927A1 Novel probiotic compositions and methods of using the same |
| 10/21/2004 | CA2505848A1 Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 10/21/2004 | CA2501222A1 Antibody recognizing antigen |
| 10/20/2004 | EP1469075A1 Gene-therapy for solid tumors, papillomas and warts |
| 10/20/2004 | EP1469009A2 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 10/20/2004 | EP1468998A1 Crystalline monohydrate of Tiotropium bromide and process for its preparation |
| 10/20/2004 | EP1468691A1 Use of bisphosphonates in the treatment of vascular restenosis |
| 10/20/2004 | EP1468683A2 Pharmaceutical composition for oral use with angiotensin-II-antagonistic activity and method of preparing it |
| 10/20/2004 | EP1468682A1 Therapeutic combinations comprising amlodipine and atorvastatin |
| 10/20/2004 | EP1468681A1 Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process |
| 10/20/2004 | EP1468679A2 Controlled release formulation containing tramadol |
| 10/20/2004 | EP1468678A1 Pharmaceutical foam aerosol comprising Dexpanthenol |
| 10/20/2004 | EP1468677A2 An antireflux syrup |
| 10/20/2004 | EP1468676A2 Poly (vinyl alcohol) cryogel |
| 10/20/2004 | EP1468663A2 Oil-water mixed composition |
| 10/20/2004 | EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein |
| 10/20/2004 | EP1468085A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 10/20/2004 | EP1467819A1 Electrostatic application of powder material to solid dosage forms |
| 10/20/2004 | EP1467791A1 Apparatuses and methods for automatically assessing and monitoring a patient s responsiveness |
| 10/20/2004 | EP1467771A2 Mycobacterial vaccine |
| 10/20/2004 | EP1467769A1 A method for preparing resinates |
| 10/20/2004 | EP1467766A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions |
| 10/20/2004 | EP1467750A1 Orodispersible pharmaceutical composition comprising perindopril |
| 10/20/2004 | EP1467749A1 Thrombin derived peptides for promoting cardiac tissue repair |
| 10/20/2004 | EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467744A2 Aqueous compositions containing metronidazole |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467737A1 Orally dispersible pharmaceutical piribedil composition |
| 10/20/2004 | EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 10/20/2004 | EP1467724A1 Orodispersible pharmaceutical composition comprising agomelatine |
| 10/20/2004 | EP1467722A2 Use of an anti-microtubule agent for the treatment of uveitis |
| 10/20/2004 | EP1467720A2 Dna dosage forms |
| 10/20/2004 | EP1467718A1 Method of treatment of a patient requiring analgesia |
| 10/20/2004 | EP1467717A1 Stable pharmaceutical compositions comprising ace inhibitor(s) |
| 10/20/2004 | EP1467716A2 Polytartrate composition |
| 10/20/2004 | EP1467715A1 Formulations for oral administration of active compounds |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467713A1 Tabletting process |
| 10/20/2004 | EP1467712A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic |
| 10/20/2004 | EP1467711A2 Dna dosage forms |
| 10/20/2004 | EP1467710A2 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support |
| 10/20/2004 | EP1467709A1 Drug nanoparticles from template emulsions |
| 10/20/2004 | EP1467708A1 New process 1 |
| 10/20/2004 | EP1467707A1 Composition for easing human childbirth |
| 10/20/2004 | EP1467706A2 Dermal application system for aminolevulinic acid-derivatives |
| 10/20/2004 | EP1467705A2 Therapeutic agent delivery tampon |
| 10/20/2004 | EP1467703A2 Method for treatment of a region of the skin of a human subject, in particular cosmetic treatment by the trans-epidermal route using projection of a liquid under pressure |
| 10/20/2004 | EP1467701A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 10/20/2004 | EP1467622A2 Mitocidal compositions and methods |
| 10/20/2004 | EP1411882A4 Cosmetic raw material having improved properties and processes for preparing the same |
| 10/20/2004 | EP1351669B1 Clear propofol compositions |
| 10/20/2004 | EP1305033B1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 10/20/2004 | EP1232252A4 Reversibly inactivated acidified plasmin |
| 10/20/2004 | EP1206268B1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 10/20/2004 | EP1183015B1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 10/20/2004 | EP1135112B1 An oral formulation for gastrointestinal drug delivery |
| 10/20/2004 | EP1115748B1 Carrageenan compositions, and processes for their production |
| 10/20/2004 | EP1109551A4 4-amino-3-mercapto-1,2,4-triazoles |
| 10/20/2004 | EP1079815B1 Timed-release transdermal systems containing an active ingredient |
| 10/20/2004 | EP1032592A4 Antimicrobial peptides |
| 10/20/2004 | EP1014805A4 Chewing gum containing physiological cooling agents |
| 10/20/2004 | EP1011643A4 Chewing gum containing controlled release acyclic carboxamides |
| 10/20/2004 | EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis |
| 10/20/2004 | EP1003569B1 Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture |
| 10/20/2004 | EP0971701B1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 10/20/2004 | EP0835099B1 A method of transfection of cells using liposomally encapsulated nucleic acids |
| 10/20/2004 | EP0763354B1 Oil/water mixture composition |
| 10/20/2004 | EP0727959B1 Diagnostic uses of hydrazinoadenosines |
| 10/20/2004 | CN2649079Y Acupoint-applied therapeutic paster |
| 10/20/2004 | CN2649078Y Triple-effect paster Babu ointment |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1539006A Lanolin substitute, production method thereof and application of same |
| 10/20/2004 | CN1538855A Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
| 10/20/2004 | CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
| 10/20/2004 | CN1538837A Swallow tablet comprising paracetamol |
| 10/20/2004 | CN1538835A Ophthalmic depot fomulations for periocular or conjunctival administration |
| 10/20/2004 | CN1538825A Biodegradable injectable implants and related method of manufacture and use |
| 10/20/2004 | CN1537946A Method of extracting dietary fiber from sogbean drges and chewing tablet |
| 10/20/2004 | CN1537899A Water-containing composition comtaining N-alkyltartaric acid imide and N-alkylmaloy |